2-[2-(1,3-benzothiazol-2-yl)-6-(1-benzothiophen-2-yl)-3-(1H-benzotriazol-4-yl)phenyl]-1,3-benzoxazole
C34H19N5OS2 — CID 141072641
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-(1,3-benzothiazol-2-yl)-6-(1-benzothiophen-2-yl)-3-(1H-benzotriazol-4-yl)phenyl]-1,3-benzoxazole
2-[2-(1,3-benzothiazol-2-yl)-6-(1-benzothiophen-2-yl)-3-(1H-benzotriazol-4-yl)phenyl]-1,3-benzoxazole (PubChem CID 141072641) has the molecular formula C34H19N5OS2 and a molecular weight of 577.69 g/mol. Its IUPAC name is 2-[2-(1,3-benzothiazol-2-yl)-6-(1-benzothiophen-2-yl)-3-(1H-benzotriazol-4-yl)phenyl]-1,3-benzoxazole.
Molecular Properties
| Compound Name | 2-[2-(1,3-benzothiazol-2-yl)-6-(1-benzothiophen-2-yl)-3-(1H-benzotriazol-4-yl)phenyl]-1,3-benzoxazole |
|---|---|
| PubChem CID | 141072641 |
| Molecular Formula | C34H19N5OS2 |
| Molecular Weight | 577.69 g/mol |
| Exact Mass | 577.10 |
| IUPAC Name | 2-[2-(1,3-benzothiazol-2-yl)-6-(1-benzothiophen-2-yl)-3-(1H-benzotriazol-4-yl)phenyl]-1,3-benzoxazole |
| SMILES | c1ccc2sc(-c3ccc(-c4cccc5[nH]nnc45)c(-c4nc5ccccc5s4)c3-c3nc4ccccc4o3)cc2c1 |
| InChI | InChI=1S/C34H19N5OS2/c1-5-14-27-19(8-1)18-29(41-27)22-17-16-20(21-9-7-12-25-32(21)38-39-37-25)31(34-36-24-11-3-6-15-28(24)42-34)30(22)33-35-23-10-2-4-13-26(23)40-33/h1-18H,(H,37,38,39) |
| InChIKey | ZAPOMPLWSGJANK-UHFFFAOYSA-N |
| XLogP | 9.59 |
| TPSA | 80.49 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 577.69 |
| LogP ≤ 5 | 9.59 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141072641 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.